SpectraScience, Inc. designs, develops, manufactures, and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The company was founded on May 4, 1983 and is headquartered in San Diego, CA.